LANTERN PHARMA INC (LTRN)
US51654W1018 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -19.09M | -15.96M | -14.26M | -12.36M | -5.91M | |||
| Depreciation Amortization | 17.33K | 14.62K | 10.00K | 10.00K | 0.00 | |||
| Change In Working Capital | 1.79M | 538.02K | -610.00K | 600.00K | -940.00K | |||
| Other non cash items | 59.40K | 1.06M | 2.09M | 1.16M | 1.19M | |||
| OPERATING CASH FLOW | -17.23M | -14.35M | -12.77M | -10.59M | -5.65M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -18.24K | -18.73K | -30.00K | -20.00K | -20.00K | |||
| Other Investing Activity | 190.15K | -911.48K | 210.00K | -19.52M | N/A | |||
| INVESTING CASH FLOW | 181.90K | -930.21K | 180.00K | -19.53M | -20.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | 0.00 | 110.00K | |||
| Stock Issued/Repurchased | -433.29K | -500.00K | -2.18M | 68.20M | 26.30M | |||
| Other Financing Activity | N/A | N/A | 0.00 | -4.78M | -2.75M | |||
| FINANCING CASH FLOW | -433.29K | -500.00K | -2.18M | 63.42M | 23.66M | |||
| Exchange Rate Effect | 9.20K | -28.46K | -10.00K | 0.00 | N/A | |||
| CHANGE IN CASH | -17.47M | -15.81M | -14.78M | 33.30M | 17.99M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.23M | -14.35M | -12.77M | -10.59M | -5.65M | |||
| Capital Expenditure | -18.24K | -18.73K | -30.00K | -20.00K | -20.00K | |||
| FREE CASH FLOW | -17.25M | -14.37M | -12.80M | -10.61M | -5.67M | |||
All data in USD